Shandong Pharmaceutical Glass Co Ltd Cash Flow Conversion Efficiency
Shandong Pharmaceutical Glass Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shandong Pharmaceutical Glass Co Ltd (600529) has a cash flow conversion efficiency ratio of 0.005x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥41.46 Million ≈ $6.07 Million USD) by net assets (CN¥8.29 Billion ≈ $1.21 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shandong Pharmaceutical Glass Co Ltd (2001–2025)
Cash flow conversion efficiency of Shandong Pharmaceutical Glass Co Ltd from 2001 to 2025. This chart illustrates how Shandong Pharmaceutical Glass Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shandong Pharmaceutical Glass Co Ltd share price for real-time trading data and today's change.
Shandong Pharmaceutical Glass Co Ltd Cash Flow Conversion Ratio Explained
Shandong Pharmaceutical Glass Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shandong Pharmaceutical Glass Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Pharmaceutical Glass Co Ltd ranked by their cash flow conversion efficiency. Also see Shandong Pharmaceutical Glass Co Ltd (600529) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhuzhou CRRC Times Electric Co. Ltd
F:ZTX
|
0.069x |
|
TBO Tek Ltd
NSE:TBOTEK
|
0.021x |
|
SES S. A.
PA:SESG
|
0.174x |
|
Malaysian Pacific Industries
KLSE:3867
|
0.040x |
|
Central Puerto S.A.
BA:CEPU
|
0.035x |
|
Iluka Resources Ltd
AU:ILU
|
-0.039x |
|
Mercuries Life Insurance Co Ltd
TW:2867
|
-0.072x |
|
Outokumpu Oyj
HE:OUT1V
|
0.015x |
Annual Cash Flow Conversion Efficiency for Shandong Pharmaceutical Glass Co Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Shandong Pharmaceutical Glass Co Ltd from 2001 to 2025. Review Shandong Pharmaceutical Glass Co Ltd (600529) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥8.29 Billion ≈ $1.21 Billion |
CN¥576.92 Million ≈ $84.42 Million |
0.070x | -52.19% |
| 2024-12-31 | CN¥8.01 Billion ≈ $1.17 Billion |
CN¥1.17 Billion ≈ $170.48 Million |
0.145x | +4.60% |
| 2023-12-31 | CN¥7.53 Billion ≈ $1.10 Billion |
CN¥1.05 Billion ≈ $153.35 Million |
0.139x | +283.58% |
| 2022-12-31 | CN¥6.96 Billion ≈ $1.02 Billion |
CN¥252.44 Million ≈ $36.94 Million |
0.036x | -77.43% |
| 2021-12-31 | CN¥4.67 Billion ≈ $683.41 Million |
CN¥750.44 Million ≈ $109.81 Million |
0.161x | +20.82% |
| 2020-12-31 | CN¥4.26 Billion ≈ $622.77 Million |
CN¥566.01 Million ≈ $82.82 Million |
0.133x | -14.13% |
| 2019-12-31 | CN¥3.87 Billion ≈ $565.98 Million |
CN¥599.05 Million ≈ $87.66 Million |
0.155x | +17.24% |
| 2018-12-31 | CN¥3.53 Billion ≈ $515.92 Million |
CN¥465.77 Million ≈ $68.16 Million |
0.132x | +4.23% |
| 2017-12-31 | CN¥3.25 Billion ≈ $475.62 Million |
CN¥411.96 Million ≈ $60.28 Million |
0.127x | -23.84% |
| 2016-12-31 | CN¥3.04 Billion ≈ $445.37 Million |
CN¥506.53 Million ≈ $74.12 Million |
0.166x | -4.43% |
| 2015-12-31 | CN¥2.24 Billion ≈ $327.41 Million |
CN¥389.63 Million ≈ $57.02 Million |
0.174x | +38.83% |
| 2014-12-31 | CN¥2.13 Billion ≈ $311.04 Million |
CN¥266.63 Million ≈ $39.02 Million |
0.125x | -5.20% |
| 2013-12-31 | CN¥2.03 Billion ≈ $297.05 Million |
CN¥268.60 Million ≈ $39.30 Million |
0.132x | +800.22% |
| 2012-12-31 | CN¥1.94 Billion ≈ $283.93 Million |
CN¥28.52 Million ≈ $4.17 Million |
0.015x | -90.10% |
| 2011-12-31 | CN¥1.85 Billion ≈ $270.68 Million |
CN¥274.63 Million ≈ $40.19 Million |
0.148x | +19.41% |
| 2010-12-31 | CN¥1.75 Billion ≈ $255.40 Million |
CN¥217.01 Million ≈ $31.76 Million |
0.124x | -20.53% |
| 2009-12-31 | CN¥1.59 Billion ≈ $233.14 Million |
CN¥249.27 Million ≈ $36.48 Million |
0.156x | +147.67% |
| 2008-12-31 | CN¥1.45 Billion ≈ $212.56 Million |
CN¥91.76 Million ≈ $13.43 Million |
0.063x | -32.69% |
| 2007-12-31 | CN¥1.31 Billion ≈ $191.22 Million |
CN¥122.63 Million ≈ $17.95 Million |
0.094x | +10.60% |
| 2006-12-31 | CN¥924.74 Million ≈ $135.32 Million |
CN¥78.47 Million ≈ $11.48 Million |
0.085x | +65.83% |
| 2005-12-31 | CN¥861.57 Million ≈ $126.08 Million |
CN¥44.09 Million ≈ $6.45 Million |
0.051x | +1202.83% |
| 2004-12-31 | CN¥797.19 Million ≈ $116.65 Million |
CN¥-3.70 Million ≈ $-541.26K |
-0.005x | -105.67% |
| 2003-12-31 | CN¥725.23 Million ≈ $106.12 Million |
CN¥59.35 Million ≈ $8.68 Million |
0.082x | -51.29% |
| 2002-12-31 | CN¥650.32 Million ≈ $95.16 Million |
CN¥109.26 Million ≈ $15.99 Million |
0.168x | +31.77% |
| 2001-12-31 | CN¥224.34 Million ≈ $32.83 Million |
CN¥28.60 Million ≈ $4.19 Million |
0.128x | -- |
About Shandong Pharmaceutical Glass Co Ltd
Shandong Pharmaceutical Glass Co.Ltd engages in research and development, production, and sale of various pharmaceutical glass packaging products in China. The company offers moulded glass products, including amber glass containers, dropper bottles, infusion bottles, cosmetic bottles, tablet bottle, food glass, cobalt blue and green bottles, and black bottles, as well as moulded glass injection v… Read more